1.
Global burden of blood-pressure-related disease, 2001
by Lawes, Carlene MM, PhD
The Lancet (British edition), 2008, Vol.371 (9623), p.1513-1518

2.
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
by Danaei, Goodarz
The Lancet (British edition), 2006, Vol.368 (9548), p.1651-1659

3.
Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
by Murray, Christopher JL
The Lancet (British edition), 2003, Vol.361 (9359), p.717-725

4.
Noncalcemic adverse effects and withdrawals in randomized controlled trials of long-term vitamin D2 or D3 supplementation: a systematic review and meta-analysis
by Malihi, Zarintaj
Nutrition reviews, 2017, Vol.75 (12), p.1007-1034

5.
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
by Jackson, Rod
The Lancet (British edition), 2005, Vol.365 (9457), p.434-441

6.
Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis
by Lawes, Carlene M M
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (1), p.69-75

7.
Methodology of the Global and Regional Burden of Stroke Study
by Bennett, Derrick A
Neuroepidemiology, 2012, Vol.38 (1), p.30-40
